Climb Bio, Inc. (CLYM) exchanged 20.4 million shares of common stock for pre-funded warrants in a deal with RA Capital Management.

Climb Bio (CLYM) exchanged 20.4 million shares for pre-funded warrants with RA Capital Management, per an SEC 8-K filing.